FHD-286 in Subjects With Metastatic Uveal Melanoma

NCT04879017 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
76
Enrollment
INDUSTRY
Sponsor class

Stopped Sponsor terminated the study for business reasons.

Conditions

Interventions

Sponsor

Foghorn Therapeutics Inc.